BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15172345)

  • 1. Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part II: Determinants operating at environmental and institutional level.
    Bates I; Fenton C; Gruber J; Lalloo D; Lara AM; Squire SB; Theobald S; Thomson R; Tolhurst R
    Lancet Infect Dis; 2004 Jun; 4(6):368-75. PubMed ID: 15172345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part 1: determinants operating at individual and household level.
    Bates I; Fenton C; Gruber J; Lalloo D; Medina Lara A; Squire SB; Theobald S; Thomson R; Tolhurst R
    Lancet Infect Dis; 2004 May; 4(5):267-77. PubMed ID: 15120343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Global Fund to fight HIV/AIDS, TB and Malaria 5-y: evaluation policy issues].
    Kerouedan D
    Bull Soc Pathol Exot; 2010 May; 103(2):119-22. PubMed ID: 20376595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender, equity: new approaches for effective management of communicable diseases.
    Theobald S; Tolhurst R; Squire SB
    Trans R Soc Trop Med Hyg; 2006 Apr; 100(4):299-304. PubMed ID: 16430933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How to combat HIV, tuberculosis and malaria?].
    Steen TW; Drage M; Solum JA
    Tidsskr Nor Laegeforen; 2009 Dec; 129(23):2504-8. PubMed ID: 19997151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Global challenges with HIV, malaria and tuberculosis].
    Ekström AM; Färnert A; Thorson A; Alfvén T
    Lakartidningen; 2013 Jan 9-15; 110(1-2):33-6. PubMed ID: 23373183
    [No Abstract]   [Full Text] [Related]  

  • 7. WHO: world may be mobilizing for battle against HIV/AIDS.
    AIDS Policy Law; 2002 Feb; 17(3):3. PubMed ID: 11873554
    [No Abstract]   [Full Text] [Related]  

  • 8. New, emerging and re-emerging infectious diseases.
    Bansal RD; Bhasin SK
    Indian J Public Health; 1997; 41(2):35. PubMed ID: 9988974
    [No Abstract]   [Full Text] [Related]  

  • 9. Implementation effects of GFATM-supported HIV/AIDS projects on the health sector, civil society and affected communities in Peru 2004-2007.
    Cáceres CF; Girón JM; Sandoval C; López R; Valverde R; Pajuelo J; Vásquez P; Rosasco AM; Chirinos A; Silva-Santisteban A
    Glob Public Health; 2010; 5(3):247-65. PubMed ID: 20390630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. African HIV/AIDS specialists recommend how US$1.5 billion Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria should be spent.
    Cent Afr J Med; 2002; 48(3-4):50. PubMed ID: 12971158
    [No Abstract]   [Full Text] [Related]  

  • 11. [The Global Fund to fight HIV/AIDS, TB and malaria policy issues].
    Kerouedan D
    Med Trop (Mars); 2010 Feb; 70(1):19-27. PubMed ID: 20337110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical interactions between Global Fund-supported programmes and health systems: a case study in Lao People's Democratic Republic.
    Mounier-Jack S; Rudge JW; Phetsouvanh R; Chanthapadith C; Coker R
    Health Policy Plan; 2010 Nov; 25 Suppl 1():i37-42. PubMed ID: 20966107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.
    Mamotte N; Wassenaar D; Koen J; Essack Z
    BMC Med Ethics; 2010 Mar; 11():3. PubMed ID: 20211030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious diseases in the Arabian Peninsula and Egypt.
    Shibl A; Senok A; Memish Z
    Clin Microbiol Infect; 2012 Nov; 18(11):1068-80. PubMed ID: 23066725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevention and control of HIV/AIDS, TB and Vector-borne diseases in informal settlements: challenges, opportunities and insights.
    David AM; Mercado SP; Becker D; Edmundo K; Mugisha F
    J Urban Health; 2007 May; 84(3 Suppl):i65-74. PubMed ID: 17431796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-pathogen interactions in emerging and re-emerging infectious diseases: a genomic perspective of tuberculosis, malaria, human immunodeficiency virus infection, hepatitis B, and cholera.
    McNicholl JM; Downer MV; Udhayakumar V; Alper CA; Swerdlow DL
    Annu Rev Public Health; 2000; 21():15-46. PubMed ID: 10884944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Institutional factors and HIV/AIDS, TB and Malaria.
    Simmonds S
    Int J Health Plann Manage; 2008; 23(2):139-51. PubMed ID: 17705194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A road map to control malaria, tuberculosis, and human immunodeficiency virus/AIDS.
    Frieden TR; Teklehaimanot A; Chideya S; Farmer P; Kim JY; Raviglione MC
    Arch Intern Med; 2009 Oct; 169(18):1650-2. PubMed ID: 19822819
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-income countries: where are we going with TB-HIV in 2009?
    Mwinga A
    Int J Tuberc Lung Dis; 2009 Jul; 13(7):797-8. PubMed ID: 19555525
    [No Abstract]   [Full Text] [Related]  

  • 20. [HIV/AIDS, tuberculosis and malaria can now be effectively combated].
    Nordström A; Dybul M
    Lakartidningen; 2013 Apr 3-16; 110(27-28):1275. PubMed ID: 23951879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.